Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of January 22, 2025 • 5:00 AM ET
As of January 22, 2025 • 5:00 AM ET
Date/Time | Source | News Release |
---|---|---|
11/14/2024 10:00 AM EST | SeekingAlpha | Chemomab Therapeutics GAAP EPS of -$0.01 beats by $0.05 |
11/14/2024 06:00 AM EST | US Earnings Reports | Expected US Company Earnings on Thursday, November 14th, 2024 |
11/14/2024 04:37 AM EST | US Earnings Reports | Expected earnings - Chemomab Therapeutics Ltd. |
08/21/2024 07:06 AM EDT | SeekingAlpha | Chemomab Therapeutics GAAP EPS of -$0.01 |
08/21/2024 07:00 AM EDT | US Earnings Reports | Expected US Company Earnings on Wednesday, August 21st, 2024 |
08/21/2024 05:38 AM EDT | US Earnings Reports | Expected earnings - Chemomab Therapeutics Ltd. |
08/12/2024 07:00 AM EDT | US Earnings Reports | Expected US Company Earnings on Monday, August 12th, 2024 |
08/12/2024 05:40 AM EDT | US Earnings Reports | Expected earnings - Chemomab Therapeutics Ltd. |
07/26/2024 07:04 AM EDT | SeekingAlpha | Chemomab Therapeutics regains compliance with Nasdaq |
07/25/2024 01:36 PM EDT | SeekingAlpha | Chemomab falls on private placement despite mid-stage win for lead asset |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.